For example, anti-ErbB2 antibodies have been used to target doxorubicin containing liposomes [3,4] or Pseudomonas exotoxin (immunotoxin) into the interior of ErbB2 overexpressing tumor cells [5,6]. This evidence concerns the gene ERBB2 and neoplasm.